Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bio-behavioral Lung Cancer Prevention Program
NCT00322205Phase 4Completed
- Sponsor
- National Institutes of Health
- Start
- Jun 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nicotine dependence comparing Bupropion + Counseling with Placebo + Counseling (2 arms). Primary endpoint: Continuous abstinence at 12 months. Started Jun 1999; status: completed.
02
Drugs
bupropion
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00322205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00322205.